Skip to main content

News

Drugmakers from Pfizer to GSK to hike U.S. prices on over 200 drugs

By Reuters  
   January 02, 2020

Drugmakers including Pfizer Inc, GlaxoSmithKline PLC and Sanofi SA are planning to hike U.S. list prices on more than 200 drugs in the United States on Wednesday, according to drugmakers and data analyzed by healthcare research firm 3 Axis Advisors.

Full story


Get the latest on healthcare leadership in your inbox.